According to Bloomberg, citing people familiar with the matter, the DOJ is set to rip up its agreement to not prosecute UBS Group AG for rigging benchmark interest rates.
The move by the US would be a first for the industry, making good on a March threat by a senior Justice Department official to revoke such agreements. UBS’s cooperation in the currency probe may help shield it from antitrust charges in that matter. However, the bank is still exposed to fraud charges in that case.
UBS had previously been among the banks expected to enter a guilty plea on Wednesday with a non-prosecution agreement. Banks entering guilty pleas also need to receive permission from the Securities and Exchange Commission to prevent the criminal cases from triggering penalties that would disqualify them from other businesses, including managing mutual funds.
Bank executives have said guilty pleas could topple their operations if they don’t first receive such waivers.
The head of the Justice Department’s criminal division Leslie Caldwell, said in March she wouldn’t hesitate to tear up non- or deferred-prosecution agreements Bloomberg reported.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas